• English
  • Sign In
  • Contact Us
Webinars » Lentivirus vector manufacturing using suspension cell line

Lentivirus vector manufacturing using suspension cell line

Gene and cell therapy has made a great breakthrough in the recent years, however the industry is facing challenges in developing stable and scalable manufacturing process for viral vectors. GenScript ProBio is dedicated in developing platforms to produce viral vectors, and currently it has robust viral vector manufacturing processes using both adherent culture and suspension culture. GenScript ProBio has vast experience in assisting several customers to submit IND to FDA and NMPA, and supporting manufacturing for clinical phase use.

In this webinar, you will learn:

  • Challenges in process development of viral vector
  • Viral vector manufacturing using adherent and suspension platforms
  • GenScript ProBio track record

  • Speaker:
    Dr. Mahmood Ali, Project Manager of Virus(R&D) Purification Process
  • Date: 11th Mar 2021
  • Time: 10:00 AM SGT

About the speaker:

Dr. Mahmood Ali is a sought after Gene Therapy expert worldwide. After getting his M.D in Imaging and Molecular Biology from China and CME for Genetics from the States, he entered the Gene and cell therapy industry to explore his passion for eliminating genetic diseases. He has completed a number of Lentivirus and AAV production batches and has deep understanding and experience in the production process.

Related services and products:

  • Plasmid CDMO service
    Different quality levels and quantity options available to follow the gene and cell therapy development process.
  • Viral vector CDMO service
    One-stop lentivirus solutions, enables smooth transition from preclinical, through clinical to commercialization.